IL4R and Alzheimer disease: To investigate the effect of the IL‐4Rα blockade through the administration of a monoclonal anti‐IL‐4Rα antibody versus that of an AIT on specific T cells deriving from AD patients with comorbid ARC, we analysed the proliferative response in parallel to the basophil activation and the sIgE levels.